A detailed history of Clark Capital Management Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 38,352 shares of EW stock, worth $2.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,352
Previous 38,352 -0.0%
Holding current value
$2.82 Million
Previous $3.54 Million 28.57%
% of portfolio
0.02%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $34,141 - $38,195
-405 Reduced 1.04%
38,352 $3.54 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $427,042 - $562,561
-5,887 Reduced 13.19%
38,757 $3.7 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $14,872 - $18,740
-241 Reduced 0.54%
44,644 $3.4 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $3,602 - $4,855
-52 Reduced 0.12%
44,885 $3.11 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $29,633 - $34,336
-364 Reduced 0.8%
44,937 $4.24 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $3.36 Million - $3.83 Million
45,301 New
45,301 $3.75 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $10,213 - $13,303
-124 Reduced 3.96%
3,004 $248,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $3,806 - $5,643
44 Added 1.43%
3,128 $297,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $44,862 - $56,469
-440 Reduced 12.49%
3,084 $363,000
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $148,173 - $182,037
1,393 Added 65.37%
3,524 $457,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $219,301 - $261,580
2,131 New
2,131 $241,000
Q2 2021

Aug 02, 2021

SELL
$83.84 - $104.76 $347,097 - $433,706
-4,140 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $9,205 - $10,608
117 Added 2.91%
4,140 $346,000
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $8,667 - $11,279
129 Added 3.31%
4,023 $321,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $120,776 - $161,518
2,099 Added 116.94%
3,894 $269,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $890 - $1,377
-17 Reduced 0.94%
1,795 $339,000
Q4 2019

Jan 27, 2020

BUY
$71.7 - $82.09 $4,373 - $5,007
61 Added 3.48%
1,812 $423,000
Q3 2019

Nov 06, 2019

BUY
$61.55 - $75.43 $8,063 - $9,881
131 Added 8.09%
1,751 $385,000
Q2 2019

Jul 12, 2019

BUY
$55.74 - $64.41 $90,298 - $104,344
1,620 New
1,620 $299,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.